SABBY 13G SRPT 5.06.16

Company

Sarepta Therapeutics, Inc.

Filed

May 6, 2016

Accession Number

0001535610-16-000148

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →